Compound to cure while reducing the bacterial infection.

Team of venture pharmaceutical companies and Osaka to develop compounds that cure while suppressing bacterial infection, susceptible to infection wound is not Fusagara for a long time "intractable skin ulcer", announced the 28th to the U.S. online science journal Purosuwan.
According to the team, the barrier function of the skin is reduced in the affected area, both wound repair and to keep the antibacterial properties can be difficult to existing drugs. Tomioka's Osaka University graduate student (clinical gene therapy studies) said, "is also effective in multiple-drug-resistant bacteria, it can also be expected to have the prevention of nosocomial infection" he said.
It is easy to place the bad part of the blood flow, it is found in arthritis patients from diabetes and, sometimes cutting the hands and feet and get worse intractable skin ulcer. Bedsore that can be bed-ridden people are also included. I would do or how long is up to practical use. We hope that they will be able to use early.


傷が長い間ふさがらず感染症にかかりやすい「難治性皮膚潰瘍」を、細菌感染を抑えながら治す化合物を大阪大とベンチャー製薬企業のチームが開発し、米オンライン科学誌プロスワンに２８日発表した。
　チームによると、患部では皮膚のバリアー機能が低下し、既存の薬では抗菌性を保つことと傷修復の両立が難しい。大阪大大学院生の冨岡さん（臨床遺伝子治療学）は「多剤耐性菌にも効果があり、院内感染の予防も期待できる」と話す。
　難治性皮膚潰瘍は血流の悪い部分に起きやすく、糖尿病やリウマチ患者らで見られ、悪化すると手足を切断することもある。寝たきりの人にできる床擦れも含まれる。実用化までにはどのくらいかかるんでしょうかね。早期に使用できるようになるといいですね。